Pharmaceutical group agrees to pay over £380,000 in care-home medicine cartel
By Simon Barnes
On 12 December 2013, the Office for Fair Trading (OFT) announced that a £380,000 settlement had been agreed in relation to a market sharing cartel involving two pharmaceutical suppliers.
The settlement follows an investigation by the OFT into agreements between Quantum Pharmaceutical and Lloyds Pharmacy under which medicines were supplied to care homes between May 2011 and November 2011.
The OFT found that the parties had colluded to ensure that Quantum’s sister, Tomms Pharmacy, would not supply prescription medicines to existing Lloyds care-home customers. In return, at least for some of the time, Lloyds agreed not to supply prescription medicines to existing care-home customers of Tomms Pharmacy…
If you are registered and logged in to the site, click on the link below to read the rest of the Shoosmiths briefing. If not, please register or sign in with your details below.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Shoosmiths
News from The Lawyer
Briefings from Shoosmiths
A $100m US settlement may be of only passing interest to the UK auto industry, but parallels can be drawn with increasing levels of regulation in Europe.
The importance of companies being able to freely advertise their fees or discounts has again been highlighted by the Competition and Markets Authority (CMA).
Analysis from The Lawyer
Compliance and corporate governance codes for large financial institutions will undoubtedly include provisions to regulate high pay in the future
There’s more to the ABS model than attracting the man in the street and procuring external investment. Partners at the big corporate firms, take note…